The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Single-agent bevacizumab for recurrent high-grade glioma.
Megan Greally
No relevant relationships to disclose
Karen Anne Cadoo
No relevant relationships to disclose
Niamh Coleman
No relevant relationships to disclose
Michelle O'Brien
No relevant relationships to disclose
Lynda M. O'Riordan
No relevant relationships to disclose
William Grogan
No relevant relationships to disclose
Oscar S. Breathnach
No relevant relationships to disclose